Plain English Summary
GHRP-2 (Pralmorelin) is a synthetic growth hormone-releasing peptide that mimics ghrelin, promoting the release of growth hormone (GH) and stimulating appetite. It has been studied for its effects on muscle and bone growth, as well as appetite regulation in humans. It is currently under investigation for clinical applications including diagnosing GH deficiency.
What People Use It For
Side Effects & Risks
Common Side Effects
References
- 1https://pubmed.ncbi.nlm.nih.gov/15230633/
- 2https://pubmed.ncbi.nlm.nih.gov/15699539/
- 3https://pubmed.ncbi.nlm.nih.gov/25869809/
- 4https://pubmed.ncbi.nlm.nih.gov/8887169/
- 5https://pubmed.ncbi.nlm.nih.gov/25809000/
- 6https://pubmed.ncbi.nlm.nih.gov/9186261/
- 7https://pubmed.ncbi.nlm.nih.gov/9798733/
- 8https://pubmed.ncbi.nlm.nih.gov/32257855/
Researchers also explore
GHRP-6 (Growth Hormone Releasing Peptide-6)
GHRP-6 is a synthetic hexapeptide that stimulates growth hormone release and exhibits potential therapeutic properties in metabolic and regenerative medicine contexts.
Semaglutide
Semaglutide is a GLP-1 receptor agonist originally developed for type 2 diabetes that has become one of the most effective weight loss medications available. It works by mimicking a natural hormone that regulates appetite and blood sugar, helping people feel full faster and longer.
Tirzepatide
Tirzepatide is a dual GIP/GLP-1 receptor agonist that has shown even stronger weight loss results than semaglutide in clinical trials. It targets two hormone pathways instead of one, making it potentially more effective for both weight loss and blood sugar control.
GIP (Glucose-dependent Insulinotropic Polypeptide)
GIP is an endogenous incretin hormone released from the gut after nutrient intake. It plays a critical role in glucose metabolism by stimulating insulin secretion in a glucose-dependent manner. While historically studied for its insulinotropic effects, modern research focuses on its systemic roles in adipose tissue, bone remodeling, and the central nervous system, particularly when combined with GLP-1 for metabolic therapies.
Researcher Sentiment
No votes yet — be the first
Educational Content Only
This is not medical advice. Always consult a licensed healthcare provider before using any compound. No dosing or sourcing guidance is provided.